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ABSTRACT
Nerve Regeneration Using Lysophosphatidylcholine and Nerve Growth Factor
Ryan LaVar Wood
Department of Chemical Engineering, BYU
Master of Science
Peripheral nerve damage affects hundreds of thousands of people every year. This study
tested the effectiveness of using lysophosphatidylcholine (LPC) in combination with nerve
growth factor (NGF) to increase the healing rate of damaged left sciatic nerves in female rats.
The rats were randomly divided into eight groups: Sham, Right Sciatic, Crush, LPC, LPC-NGF,
Crush- LPC, Crush-NGF, and Crush-LPC-NGF. The healing of the nerves was measured by
monitoring gait, electrophysiological parameters (compound muscle action potential amplitudes
and nerve conductance velocities) and morphological parameters (total fascicular area, total
myelinated fiber counts, fiber densities, fiber diameters, and g-ratio). Gait and
electrophysiological parameters were measured three times a week. Morphological parameters
were measured at three weeks and at six weeks. The LPC and LPC-NGF groups were not
statistically different from the controls (Sham and Right Sciatic) at either of the morphological
time points but were statistically different from the controls for the first three weeks for the
electrophysiological parameters and gait. The LPC-NGF group did not differ from the LPC
group at any time point for any of the parameters. Crush, Crush-LPC, Crush-NGF, and CrushLPC-NGF groups statistically differed from the controls at week 3 for all parameters and only in
the electrophysiological parameters at week 6. Crush-LPC, Crush-NGF, and Crush-LPC-NGF
did not differ from each other or from the Crush group. The combination of LPC and NGF did
not prove to be an effective treatment for peripheral nerve damage. Future work is recommended
to test multiple injections of LPC and NGF.
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INTRODUCTION

Every year, hundreds of thousands of patients suffer traumatic injuries to the peripheral
nervous system. Often, these injuries destroy motor and sensory function in limbs. Many of these
patients permanently lose sensory or motor function. This study was designed to simulate
traumatic injury to the sciatic nerve in rats to understand the degeneration and subsequent
regeneration processes of nerve fibers.
Society and the scientific community have benefited from an increased understanding of
demyelination and the role of the extracellular matrix (ECM) in peripheral nerve regeneration.
Damaged peripheral nerves generally regenerate only a fraction of lost motor and sensory
function. This experimentation was initiated to determine factors that induce and encourage
proper regeneration of peripheral nervous tissue. The human body innately has the capacity for
some neural regeneration, but to an extent that is less than desirable. The goal of this study was
to improve the rate of regeneration through a combination of a lipid and a growth factor that
could lead to desirable changes in clinical practice for injured persons and improve the quality
of life.
This study hypothesized that the healing rate of a crushed nerve would increase through
an application of a combination of lysophosphatidylcholine (LPC) and nerve growth factor
(NGF). The novelty of this approach was the combination of LPC and NGF to improve
regeneration. LPC causes demyelination but it does not affect the ECM. Demyelination
1

upregulates nerve growth factor receptors (NGFRs), which are essential for the repair and
regeneration of nerves. Crushing the nerve also causes demyelination, but this demyelination
occurs over time from ECM degeneration (Rotshenker, 2011). LPC was used to improve the
regenerative capacity of crush-injured peripheral nerves by accelerating the demyelination
process to increase the number of NGFRs, allowing the NGF to interact with the NGFRs sooner
and speed up the healing process.
In addition to comparing the effects of a crushed nerve with and without LPC and NGF,
LPC was used without NGF for comparing regeneration rates with the ECM intact, although
damaged. The investigation focused on the in vivo effects of LPC and NGF by introducing them
locally at the site of injury. The methods of analysis were: electromyography, light microscopy,
and gait observation. Electromyography enabled us to quantitatively evaluate the response of
skeletal muscle after stimulation. Light microscopy revealed the structural integrity of the axons
and ECM in the peripheral nervous system. Gait provided an additional way to measure healing
and functional recovery through observation of movement.
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LITERATURE REVIEW

Background
The peripheral nervous system (PNS) is prone to injury, often disrupting the normal
functions of sensory and motor neurons by damaging the integrity of axons and Schwann cells
(Richner et al., 2014). Damage to the adult peripheral nerves induces cellular responses
resembling cellular activity during development (Shakhbazau et al., 2012).
During development, the PNS strongly depends upon protein stimulation for neuronal
differentiation, growth, and maturation (Richner et al., 2014). Proteins, such as neurotrophins
and surface-bound matrix molecules, guide developing axons to their innervating targets (Du et
al., 2011). The proteins act by either repelling or attracting the growth cone. Multiple
neurotrophins create crosstalk between growth pathways and add complexity to axonal growth
(Yu et al., 2010). To decrease crosstalk, neurotrophins often are upregulated to direct axonal
growth (Li et al., 2012). The downside of simply overexpressing neurotrophins is that the
oversupply traps the growth cone, causing misdirection in regenerating axons (Shakhbazau et al.,
2013).
Neurotrophins
After injury there is a rapid and robust increase in the synthesis of neurotrophins in
neurons and Schwann cells, guiding and supporting regeneration (Fan, 1992, Shakhbazau et al.,
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2012). Neurotrophins (e.g., NGF, BDNF, NT-3, CNTF, GDNF, and VEGF) guide axonal growth
(Yu et al., 2010). Zochodne and Cheng (2000) found an insignificant increase in neurotrophins
around the proximal nerve stump after damage. Thus, alternative methods, such as cell therapy
or neurotrophin injection, provide the damaged nerve with neurotrophins (Toews et al., 1997).
Hoyng et al. (2014) found that only three neurotrophins play a critical role in nerve
regeneration. In testing BDNF, CNTF, GDNF, NGF, NT3 and VEGF, they discovered that only
BDNF, NGF, and GDNF increased axonal regeneration. However, BDNF and GDNF were
lacking in motor neuron recovery and NGF was lacking in sensory recovery. Kemp et al. (2011)
found that applying an optimal concentration over a long period did not oversaturate the
receptors but provided faster regeneration. Shakhbazau et al. (2013) found that time-release of
GDNF prevented axonal trapping in GDNF-enriched areas, and improved functional recovery.
Receptors
Neurotrophins signal two receptors, the p75 neurotrophic receptor and the tropomyosin
receptor kinase (Trk) (Richner et al., 2014). There are three Trk receptors: TrkA, the high
affinity receptor for NGF; TrkB, the high affinity receptor for BDNF; and TrkC, the high affinity
receptor for NT-3 (Mu et al., 1993). The p75 receptor has low affinity for all neurotrophins,
whose expression increases after injury (Jung et al., 2011).
After injury, neurotrophin receptors are upregulated on the distal portion of the nerve, on
denervated Schwann cells and on the growth cones of regenerating axons (Raivich and
Kreutzberg, 1994). Webber et al. (2008) found that TrkA levels increase on the denervated
Schwann cells and regenerating axons. Funakoshi et al. (1993) found that TrkB and TrkC have
reduced levels on the denervated Schwann cells. After injury, Curtis et al. (1998) found that
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sensory neurons depend on neurotrophin binding to the p75 and Trk receptors, but motoneurons
only depend on neurotrophin binding to the p75 receptor.
The role of the p75 receptor is controversial as it can exert pro-apoptotic functions (Fukui
et al., 2010). In their experiments, Kemp et al. (2011) applied a p75 inhibitor and discovered that
completely blocking this receptor stunted nerve growth. They discovered that surpassing a
critical level switches p75 activation from a growth-promoting to an inhibitory influence (Kemp
et al., 2011). Cosgaya et al. (2002) found that the p75 receptor was a positive modulator of
myelination. Ma et al. (2013) found that Schwann cells promote peripheral nerve regeneration
through the increased expression of the p75 receptor, confirming Cosgaya’s findings.
Schwann Cells
Schwann cells play a key role in axonal regeneration. Schwann cells are the glial and
myelinating cells in the PNS, support peripheral axon regeneration, and remyelinate the axon
after injury (Shakhbazau et al., 2012). After injury, the axons begin to degenerate distal to the
injury site, causing the Schwann cells to lose contact with the axons. This loss of contact downregulates markers of myelination and begins up-regulating developmental markers (Scherer et
al., 1994). This causes the Schwann cells to revert to a pre-myelination state. During this premyelination state, Schwann cells increase their neurotrophic receptors and produce more
neurotrophins supporting regeneration (Scherer et al., 1994).
During regeneration, Schwann cells form Bands of Bungner (Ribeiro-Resende et al.,
2009). Bands of Bungner create a chain of Schwann cells that extend from the distal stump of the
damaged nerve to the growing axons (Hall et al., 1997). This chain serves as a guide to direct
growing axons to the distal stump (Ribeiro-Resende et al., 2009). As axons grow, they search for
neurotrophins and the Bands of Bungner (Bozkurt et al., 2012). Once the Bands of Bungner are
5

found, the axons begin moving down the chain to the distal stump. After the ends of the axons
meet, NGF signals the Schwann cells to remyelinate the axons, completing the healing process
(Chan et al., 2004).
Time
The capacity of Schwann cells to support regeneration decreases with time (Gordon et al.,
2003). Ma et al. (2011) found that Schwann cells at the motor endplate could prevent functional
synapses of the motor axon with the muscle and reject regeneration after long periods of
denervation. Thus, it is important to achieve early repair or to accelerate the regeneration.
While the nerve can produce all of the necessary factors and receptors to heal itself, it
cannot always produce them fast enough or in high enough quantities (Witzel et al., 2005).
Increasing the severity of the injury or the length of the damaged nerve decreases the ability of
the nerve to heal itself and functionally recover (Allodi et al., 2012). Thus, a method that will
either accelerate the regeneration process or decrease the healing distance will increase the
functional recovery of the nerve.
Limitations
Neurotrophin supply, neurotrophic receptor quantity, and regeneration time are the main
areas that need assistance in helping a damaged nerve regrow. Neurotrophin supply and
neurotrophic receptor quantity are constantly being addressed to decrease regeneration time.
Shakhbazau et al. (2012) addressed neurotrophin supply and found that over-expressing NGF in
Schwann cells leads to an increase in neurotrophin supply at the earliest stages of regeneration.
This increase promoted nerve growth after two weeks. Stoll et al. (1993) and Wuhanqimuge et
al. (2013) addressed neurotrophic receptors. In these studies, the Schwann cells associated with
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the demyelination increased expression of the p75 receptor (Stoll et al., 1993) and the TrkA
receptor (Wuhanqimuge et al., 2013).
Many researchers are attempting to accelerate regeneration rates. No prior investigation
has attempted to accelerate degeneration rates as a way to increase regeneration rates. The
closest idea is upregulating the NGF receptors. Two investigators have reported on their
attempts. Stoll et al. (1993) indicates that the expression of the p75 NGF receptor on Schwann
cell membranes is upregulated by LPC. The adminstration of LPC induces acute demyelination
(Pourabdolhossein et al., 2014), which stimulates NGF receptor p75 expression. According to
Lee et al. (1994), increasing the NGF and p75 levels near the lesion site should help increase the
rate of axon regeneration. The hypothesis of this study is that the regeneration will be accelerated
by accelerating demyelination through the use of LPC followed by an increase in the amount of
NGF. The approaches in the literature helped formulate this hypothesis.
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OBJECTIVE

The aim of this research was to increase the healing rate of a crushed sciatic nerve
through the application of LPC and NGF. NGF is a widely used and accepted means of
facilitating healing in damaged nerves. Therefore, the principal purpose was to investigate the
effects of LPC on a damaged nerve and the combination effect of LPC and NGF, due to LPC’s
ability to increase the number of receptors for NGF (Stoll et al., 1993). In addition, LPC causes
Schwann cells to detach from the axons, which is a necessary step in healing.
In order to best understand the effects that LPC had on the nerve, the rate of healing of a
rat’s sciatic nerve under normal physiological conditions was established. This included
establishing a healing rate for a crushed nerve and a nerve that received only LPC. Once this was
accomplished, NGF was added to both the crush and LPC groups to establish the rate of healing
of a rat’s sciatic nerve under improved conditions. Then NGF and LPC were added to a crushed
nerve to test our hypothesis. The healing rates were determined by monitoring the rat’s gait,
measuring nerve conduction through electromyography, and measuring the fiber density, fiber
size, fiber diameter, axon diameter, and g-ratio of each nerve. Each group of rats was compared
to each other and to two control groups: the right sciatic nerve and a sham group, which
underwent surgery but received no damage.
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EXPERIMENTAL METHODS

Materials
The rats used in this study were Wistar Albino rats of the strain Rattus norvegicus. All
rats were 15 weeks old between 250-300 g and female. Animals were caged in groups of three
until surgery in which they were separated into their own cages.
The nerve growth factor used in the study was human derived beta NGF (Sigma-Aldrich,
St. Louis, MO). This was delivered to the nerves at a concentration of 160 ng/ml. This was
prepared by mixing 0.1 mg of NGF with 1 mL of bovine serum albumin (Promega, Madison,
WI). Thirty-two µL of this solution was removed and added to 968 µL of saline. Then 100 µL of
this solution was removed and added to 900 µL of saline. This produced a 2X concentration for
NGF, which was then added to a 2X solution of fast green to create the correct NGF
concentration. The fast green provided a color to the solution for visual verification during
injection. The NGF is highly homologous between rats and humans. The bovine serum albumin
is homologous between rats and bovine. No immune response would be expected.
The lysophosphatidylcholine used in the study was egg derived LPC (Sigma-Aldrich, St.
Louis, MO). This was delivered to the nerves at a concentration of 1 mg/ml. The solution was
prepared by mixing 20 mg of LPC with 10 mL of saline. This produced a 2X concentration for
LPC, which was then added to a 2X solution of fast green to create the correct LPC
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concentration. The fast green provided a color to the solution for visual verification during
injection.
Fast green (Sigma-Aldrich, St. Louis, MO) was prepared by mixing 20 mg into 10 mL of
distilled water. This provided the needed 2X concentration which would allow the solution to
retain its color when added to either the NGF or LPC solutions.
The phosphate buffer used for preserving the nerves was made as follows. In a 150 mL
beaker, 0.18 grams of monobasic sodium phosphate hydrate (NaH2PO4•H20), 2.32 grams of
dibasic sodium phosphate heptahydrate (Na2HPO4•7H20) and 0.5 grams of sodium chloride
(NaCl) (Fisher Scientific, Pittsburg, PA) were dissolved in 100 mL of distilled water.
Karnovsky’s fixative was prepared in two steps. The first step was to make a 4.67%
paraformaldehyde solution and then make the fixative. For the paraformaldehyde solution, 3.5
grams of paraformaldehyde were dissolved in 75 mL of distilled water in a 100 mL beaker with a
magnetic stir bar. The solution was heated to 60-65 oC and stirred at 800 rpm for 30 min. Then 1
N NaOH was added one drop at a time until the solution became clear (about 7-10 drops). The
solution was removed from the heat and allowed to cool, while continuing to stir. Then 0.0001 M
HCL, at pH 4, was added one drop at a time until the solution was at pH 8. For the fixative, 10
mL of a 10% aqueous glutaraldehyde solution were added in a second 100 mL beaker. Then 17.2
mL of the paraformaldehyde made in step one were added. Then 12.8 mL of a phosphate buffer
were added. All of the components were stirred together to result in 40 mL of Karnovsky’s
fixative.
The Spurr’s resin used for embedding the dehydrated nerves was made as follows. Ten
grams of ERL 4221, 7 grams of diglycidyl ether of poly(propylene glycol) (DER 736), 26 grams
of nonenyl succinic anhydride modified (NSA), and 0.4 grams of Dimethylaminoethanol
12

(DMAE) (Ted Pella Inc., Redding, CA) were weighed out and mixed in a 50 mL beaker. All of
the components were stirred together, and produced 40 mL of Spurr’s resin.
Procedures
This study contained five main procedures: gait analysis, electromyography, surgery,
nerve preparation and nerve analysis. These procedures were performed on all groups of rats and
were approved by the Institutional Animal Care and Use Committee (IACUC) at Brigham
Young University, Protocol 14-0301 (see Appendix A).

Gait Analysis
The Basso-Beattie-Bresnahan (BBB) scale characterizes rat gait and ranges from 0-21 (de
Barros Filho and Molina, 2008). The score tracks recovery and categorizes combinations of rat
joint movement, hind limb movements, stepping, forelimb and hind limb coordination, trunk
position and stability, paw placement and tail position. Each rat was assessed one day prior to its
surgery using the BBB scale (see Appendix A). After surgery, the rats were assessed three times
a week using the BBB scale for the duration of the rat’s experimental process, either three or six
weeks.

Electromyography
Each rat received transdermal electromyography to measure nerve conductance.
Conduction through the sciatic nerve fibers was examined under general anesthesia with two
percent isoflurane. For electromyography, stainless steel needles were inserted close to the left
sciatic nerve to stimulate the nerve at three locations: ankle, knee, and hip. At each location the
needle close to the nerve acted as the cathode, and a remote subcutaneous needle as the anode. A
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recording needle was placed through the plantar muscles (the sole of the foot) with a reference
needle placed subcutaneously in the heel, see Figure 1. Supramaximal stimulations evoked
compound muscle action potentials (CMAPs) that were amplified and displayed using a National
Instruments multi-function data acquisition and LabVIEW software. The difference in base line
and the negative peak of CMAPs defined the signal amplitude. Motor nerve conduction velocity

Knee
Reference

Hip
Reference

Hip Stim

Ground
Knee Stim

Crush or
Injection Site
Ankle
Reference

Ankle Stim

Recording
Needle

Recording
Reference
Figure 1: Electrophysiology Needle Placement and Injury Site Diagram
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(NCV) was measured as the distance between the cathode needles divided by the difference
between the latency of two recordings. The NCV was measured between both the ankle and the
knee, and the knee and the hip.
The rats in each group were assessed one day prior to surgery to establish pre-surgery
amplitudes and velocities. Post-surgery, the rats received electromyography three days a week
for the duration of the rat’s experimental process, either three or six weeks. The first post-surgery
electromyography was performed within 24 hours of the surgery.

Surgery
Seven groups of rats (N=6-17) received surgery in which their left sciatic nerves were
exposed. Four groups (Crush, Crush-LPC, Crush-NGF, Crush-LPC-NGF) had their sciatic
nerves crushed and five groups (LPC, LPC-NGF, Crush-LPC, Crush-NGF, Crush-LPC-NGF)
received an intraneural injection of LPC and/or NGF. The controls (Sham, Right Sciatic) in the
study were used for comparison to reduce variability in the results. The Sham group had their
sciatic nerve exposed but received no injury to account for trauma based on initial surgery
procedures. The Right Sciatic group was used as a non-surgical control for normal variation in
rats.
Each surgery consisted of the following three protocols: pre-surgery, surgery, and postsurgery. The pre-surgery protocol consisted of the following procedure: twenty-four hours before
surgery, the animals were premedicated with carprofen (Bio-Serv, Flemington, NJ), which is an
NSAID pain reliever in the form of a chewable tablet. Surgical equipment was sterilized by
autoclaving and placed on the operating table. The operating table and all equipment that could
not be autoclaved, such as the microscope and the manipulator, were sterilized with 70% ethanol
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(Decon Laboratories Inc., King of Prussia, PA) and chlorhexidine (Vet One, Boise, ID).
Materials, such as gloves and gauze, were pre-sterilized. Masks and gloves were worn by the
surgeon and assistant for the duration of the surgery to maintain the sterile field. Once the sterile
field was established, the rat was brought in and anesthetized for the surgery. The rats were
anesthetized through the respiration of gaseous isoflurane at three percent for approximately five
minutes, or until proper analgesia and sedation was confirmed by applying pressure to the left
foot and receiving no response from the rat. The rats then received an injection of the opioid
analgesic buprenorphine (Sigma-Aldrich, St. Louis, MO) into the peritoneal cavity. The left leg
was then shaved and the rat was placed on the operating table. When moved to the table,
anesthesia was monitored so that the rat breathed once every three to four seconds. The shaved
portion of the leg was treated with three alternating rubs of 70% ethanol and betadine (Dynarex,
Orangeburg, NY), and a sterilized drape was placed over the rat with an opening for the cleaned
region on the leg. The rat’s body temperature was monitored by a rectal thermometer and
maintained at 37.4 oC by a heating pad driven by a feedback-regulated controller. A towel was
placed between the rat and the heating pad to minimize the chance of burning.
The surgery protocol consisted of two procedures, a crush and an injection procedure. For
both procedures, a 1cm incision was made starting at the hip and moving towards the knee, and
the gluteus superficialis, biceps femoris, and vastus lateralis muscles were separated to expose
the sciatic nerve. Once the muscles were separated, a glass hook was used to separate the nerve
from the surrounding fat and connective tissue, and provide a reference point for both the crush
point and injection points. For crush and NGF injections, the injury site was measured 0.5 cm
proximal to the trifurcation into the tibial, sural, and common peroneal branches and the glass
hook was placed on the distal side of the measurement. For LPC injections, the injury site was
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measured 0.5 cm proximal to the bifurcation into the tibial and common peroneal branches and
the glass hook was placed on the proximal side of the measurement. Once the hook was in place,
the surgeon followed the crush and/or injection procedure.
For the crush procedure, forceps were used to crush the nerve. This was done by placing
the forceps proximal to the glass hook with the tips approximately 3 mm past the edge of the
nerve. A force was then applied for 20 seconds, released, and then reapplied for 10 additional
seconds. The rat’s leg was observed during the crushing to ensure that there was no movement
during the last 10 seconds of the crush. If movement was detected, an additional 10 seconds were
added. The force applied to the rats was not measured, since the force was applied by hand, but
each surgeon was told to apply a maximum force. The nerve was also verified visually to ensure
that the nerve had become less opaque and more transparent (Erturk et al., 2012). Crush surgeries
were confirmed if the CMAP amplitudes were equal to or less than 0.2 mV in the first postsurgery electromyography recording.
There were two types of injections, a LPC injection and a NGF injection. The injections
differed only in the placement and direction of injection. The LPC injection was performed 3
mm proximal to the location of a crush and the fluid was injected towards the distal side. The
NGF injection was performed 3 mm distal to the location of a crush and the fluid was injected to
the proximal side. For both injections, a surgical microscope and syringe manipulator were used
to insert a 10 µm tipped, glass needle into the nerve, parallel to the direction of the nerve fibers.
A total of 15 µL of fluid was injected into the nerve through a left, center, and right side
injection. The solution contained fast green for verification of a correct needle placement and
delivery. The injection was verified by a stripe running down the nerve. Rats that were
designated to receive both a crush and a LPC injection received the crush first, followed by the
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LPC injection. All rats administered NGF received this injection procedure a week after the
initial crush and/or LPC injection.
After the crush and/or LPC/NGF procedure, the nerve was released from the glass hook
and moved back into place with the hook. The incision site was then closed up using surgical
staples and Neosporin® containing a topical analgesic. The rats were then taken off anesthesia
and monitored for 20 minutes after waking up.
Rats were monitored every 12 hours for the next 48 hours and then daily after the first 48
hours for the duration of the study. Pain level was monitored according to an institutional
veterinarian-approved protocol which divided pain into four categories: weight, clinical signs,
appearance, and behavior (the protocol is attached in Appendix A). In each category the rats
received a score ranging from 0-3. If the rats received a 3 in any category or a combined total
greater than 7, the rats were euthanized. If the rats received a 2 in the weight category or the
score totaled more than 4, buprenorphine was administered to the rat.

Nerve Preparation
Following the 3-week or 6-week time period, animals were euthanized using 5%
isoflurane for 30 min. Euthanasia required 30 min because the rats became accustomed to
isoflurane. The sciatic nerve from the left leg was dissected free and a 1 cm section was cut out
from the point of the trifurcation moving proximal. For the rats in the Right Sciatic group, the
right sciatic nerve was removed using the same technique as for the left sciatic nerves. The nerve
was post-fixed in Karnovsky’s fixative (2% paraformaldehyde/4% glutaraldehyde solution in a
phosphate buffer) overnight at 4 °C.
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Nerve segments were rinsed at room temperature in phosphate buffer for 1 hour and
placed in 2% osmium tetroxide in 0.06 M sodium cacodylate buffer for 2 hours. A cacodylate
buffer was used because the osmium reacted slightly with the phosphate buffer. The nerves were
then washed in distilled water for 1 hour and placed in 5% uranyl acetate in distilled water
overnight at 4°C in complete darkness. Nerve segments were then dehydrated through a graded
acetone series (10%, 30%, 50%, 70%, 90%, 95%, 100%), cleared through a graded resin series
(33%, 66%, 100%), and embedded in Spurr’s Resin. Sections were cut at 1 µm using an RMC
MTX microtome (Boeckeler Instruments, Tucson, Arizona), placed on Superfrost Plus glass
slides (StatLab, McKinney, TX), and stained with toluidine blue (Sigma-Aldrich, St. Louis,
MO). Sections were cover slipped using permount (Electron Microscopy Sciences, Hatfield,
PA).

Nerve Analysis
For the analysis of the nerve, the distal segment of the nerve was cut off at 3 mm from the
trifurcation and sectioned moving distally. This provided an ideal area for analyzing the damage
and growth of the nerve due to the treatments. Nerve section images were obtained using a
Pentax K100 camera (Ricoh, Malvern, PA) attached to a Zeiss Axiovert 135 microscope (Zeiss,
Thornwood, NY) and analyzed using ImageJ (U. S. National Institutes of Health, Bethesda,
MD). Whole nerve images were obtained at 400x final magnification. For whole nerve imaging,
serial overlapping images were taken over the entire area of interest by manually adjusting the
stage area. Mosaic images were formed by reconstructing the images in Adobe Photoshop CS
(Figure 2) from which morphometric parameters were derived. The morphometric parameters
were calculated using a semi-automated process in ImageJ. Calculated morphometric parameters
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were total fascicular area, total myelinated fiber counts, fiber densities, mean fiber diameters,
and g-ratio. A fiber consisted of the axon and myelin together.
For the semi-automated process, the brightness and contrast were manually adjusted to
the edges of the histogram to better represent the range of image values on the scale. The images
were then converted to an 8-bit grey scale image. The threshold value was also manually
adjusted to include all parts of each axon. This then created a black and white image in which all
values below the threshold value were white and all values above were black. Myelin features
were usually darker than the rest of the image, so the background was usually under the
threshold value. The image was then analyzed using ImageJ’s Analyze Particles. This provided a
defined area range and circularity range to be analyzed. The area range was determined by
measuring the smallest and largest axon diameters and calculating their areas. As most axons
were fairly circular, the circularity range was chosen to be 0.5-1. An image mask was created
with only the particles that fit inside both the area and circularity ranges. Non-axonal particles
that were created in the mask were removed by hand by overlaying the original image with 50%
opacity and filling in the non-axon regions (Hunter et al., 2007).
Using the overlay, the axons, which were not detected in the particle analysis, could be
hand selected on the threshold image. A second mask was created which contained only the
selected axons. The two mask images were then merged, with the resulting image containing all
of the axons in the nerve, see Figure 3. The particle analysis was repeated with the area range set
to 0-10,000 µm and the circularity from 0-1. This allowed the program to pick up all the axons
and the results provided the total number of axons, the area and perimeter of each axon, and the
diameter at the widest and narrowest part of the axon.
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The process for detecting fibers was very similar. In order for the program to detect
whole fibers, the resulting axon image from the first part was added to the threshold image,
which filled in the axon center in each fiber. ImageJ’s Analyze Particles was then run again,
using the values for the smallest and largest fiber for the area range and choosing 0.5-1 for
circularity. The original image was overlaid to determine which fibers were not analyzed and
which areas were not actual fibers. The undetected fibers were added in the same fashion as the
undetected axons and the fibers were re-analyzed. The results produced a similar analysis as
before, only this time for the fibers (axon + myelin).

Figure 2: A whole nerve merged together from individual pictures.
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From the results of analyzing the fibers and the axons, the total number of myelinated
axons and the total number of axons were provided. The g-ratio was determined by first
subtracting the axon area from the fiber area to obtain a myelin area and then dividing the myelin
area by the axon area. Fiber densities were calculated by dividing the myelinated fiber count by
the total fascicular area. The total fascicular area for each nerve was calculated by manually
tracing the inner edge of the perineurium for all fascicles and then finding the area of each
selection using ImageJ. Figures 2 and 3 show the process of determining the morphology of the
nerve.

A

B

Figure 3: A. Nerve grey scaled for analysis. B. Analyzed axons of nerve.
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Statistics
Total fascicle areas, myelinated fiber counts, fiber densities, fiber packing, mean g-ratio
values, NCV and conduction amplitudes were compared between all the groups for both 3-week
and 6-week time points using a one-way ANOVA with a Dunnett’s T3 post-hoc test. Fiber
diameter distributions were compared using a Wilcoxon signed-rank test. Outliers in data sets
were identified using interquartile criteria prior to statistical tests (outliers were above or below
Q3/Q1 +/- 1.5*IQR respectively). P-values below 0.05 were considered significant. All data
were represented as the mean ±95% confidence intervals.
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ESTABLISHING A NORMAL HEALING MODEL

To determine the effectiveness of the LPC-NGF combination, it was necessary to
establish how a crushed nerve heals under normal conditions. The groups of nerves analyzed in
this section include the Right Sciatic (n=6), Sham (n=12), Crush (n=14), and LPC (n=17) groups.
Gait Results
Gait measurements were carried out as previously outlined in section 4.2.1. Experimental
results are shown in Table 1 and Figure 4 for the Right Sciatic, Sham, Crush, and LPC groups
beginning with the day before surgery, week 0, through week 6. Both the Crush group and LPC
group significantly deviated from the control groups during week 1. The rats in the crush group
lost nearly all use of the left leg from the knee down after surgery, while the LPC rats only had a
decrease in foot usage. The decrease in mobility of the Crush group was sustained throughout the
first four weeks being significantly different for the first three. The LPC group returned to
normality by the fourth week. All of the crushed rats returned to full gait by week 6.
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Table 1: Gait Results for Right Sciatic, Sham, Crush, and LPC groups
Crush
LPC
Sham
Right
Sciatic

Week 0

Week 1

Week 2

Week 3

Week 4

Week 5

Week 6

20.93±0.14 4.15±0.90* 7.30±1.04* 10.94±1.13* 15.88±0.80* 18.95±0.58* 20.77±0.21
20.88±0.16 13.17±2.40* 17.46±2.02* 19.11±1.48* 20.95±0.10 20.95±0.11 20.94±0.12
20.92±0.16 20.52±0.41 20.94±0.13 20.96±0.12 20.97±0.10 20.98±0.08 21.00±0.00
21.00±0.00

20.80±0.33

20.96±0.16

20.94±0.20

20.96±0.12

20.94±0.13

21.00±0.00

* indicates statistical differences from the other groups at that week, p<0.05.
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Figure 4: Gait comparison of the Right, Sham, LPC, and Crush groups. Error bars
represent the 95% confidence intervals. * indicates statistical differences from the
other groups at that week (p<0.05).
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Electrophysiology Results
Electrophysiology measurements, which were previously outlined in section 4.2.2, were
split into CMAP amplitudes and NCV values. The CMAP amplitudes are displayed in Table 2,
Figure 5, and Figure 6. The NCV values are displayed in Table 3, and Figure 7. There was a
small difference in the baseline values (Week 0) for each of the groups, but all were statistically
not different for both the CMAP amplitudes and NCVs.
Following surgery, an absence of CMAP amplitudes was observed in the Crush group.
The Crush group slowly increased in CMAP amplitude across the 6-week period. The Crush
group recovered to 16% of the baseline value after week 6 and was statistically different from all
other groups every week. The LPC group sustained a decrease in CMAP amplitudes following
surgery and recovered by week 4. The LPC group statistically differed from all other groups
through week 3. Both control groups: Right Sciatic and Sham, maintained their CMAP
amplitudes across the weeks and were never statistically different from each other. This shows
that the incisions and separating of the muscles did not have any measurable impact on the nerve.
The NCV measurements followed a similar pattern as the CMAP amplitudes for the
Crush and LPC groups. The Crush group had a significantly different NCV for all six weeks
from the control groups, and only statistically differed from LPC at week 1. The LPC group
NCVs were significantly different than the two control groups for the first three weeks. Both
control groups maintained their NCV values across all six weeks and never differed one from
another.
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Table 2: Electrophysiology Results for Right Sciatic, Sham, Crush, and LPC groups
Group
Crush
LPC
Sham
Right
Sciatic

Week 0

Week 1

Week 2

Week 3

Week 4

Week 5

Week 6

11.57±1.28 0.32±0.23* 0.76±.54* 0.84±0.48* 1.05±0.71* 1.85±0.84* 1.89±0.46*
12.25±1.51 5.06±1.58* 6.02±1.72* 7.02±1.30* 8.89±0.69 9.57±0.93 10.14±0.96
11.65±1.81 10.60±1.21 10.79±0.97 11.69±1.28 11.34±1.23 11.29±1.07 11.64±0.48
11.34±1.58 11.08±1.66 11.26±1.49 10.94±1.77 11.54±1.62 11.38±1.54 11.67±1.39
* indicates statistical differences from the other groups at that week, p<0.05.
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Figure 5: The amplitudes of the CMAPs for the Right, Sham, LPC and Crush groups
across all six weeks. Error bars represent the 95% confidence intervals. * indicates
statistical differences from the other groups at that week (p<0.05).

28
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Day 21

Day 1

Day 42
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1 ms

Right

Sham
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Crush

Figure 6: Representative traces of the CMAP for the Right, Sham, LPC and Crush
groups for the day before surgery (pre-op), the day after surgery (day 1), the 3-week time
point, and the 6-week time point.
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Table 3: NCV Results for Right Sciatic, Sham, Crush, and LPC groups
Group

Week 0

Week 1

Week 2

Week 3

Week 4

Week 5

Week 6

Crush
62.8±15.6 19.9±6.5* 27.4±5.1ǂ 35.9±4.7ǂ 37.3±7.1 36.3±5.2 38.3±3.9
LPC
58.2±8.4 38.1±8.4* 38.6±13.7 43.9±7.3 48.4±6.9 50.8±8.8 61.5±7.9
Sham
67.3±17.2 65.8±15.8 56.3±14.2 65.3±22.4 72.1±25.0 72.1±22.7 63.7±16.7
Right Sciatic 61.4±20.5 62.3±12.3 64.3±21.4 62.4±17.0 65.4±23.0 63.1±24.3 66.7±22.9
* indicates statistical differences from the other groups at that week, p<0.05. ǂ indicates statistical
differences from the control groups at that week, p<0.05.
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Figure 7: The NCV values for the Right, Sham, LPC and Crush groups across all
six weeks. Error bars represent the 95% confidence intervals. * indicates
statistical differences from the other groups at that week (p<0.05). ǂ indicates
statistical differences from the control groups at that week (p<0.05).
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Morphology Results
Regenerated nerve fiber profiles were examined using light microscopy at three and six
weeks after damage to determine the healing of damaged nerves and the Schwann cell’s ability
to remyelinate axons, which were previously outlined in section 4.2.5. Table 4 compares the total
fascicular area, total myelinated fiber counts, fiber densities, fiber packing and g-ratio of the
control groups to the damaged groups after three weeks of healing. The Crush group was only
significantly different than the two control groups in the fiber count, fiber packing and mean gratio. The diameters of the nerve fibers were measured for each group (Figure 8). All nerve fibers
ranged between 0 and 20 µm for each group. The distribution of the size of the healing nerve
fibers in the distal nerve stump of the Crush group varied slightly from the rest of the groups by
having a higher percentage of smaller diameter fibers. None of the groups were statistically
different from one another in fiber diameters.
Table 5 shows the total fascicular area, total myelinated fiber counts, fiber densities, fiber
packing and g-ratio of the control groups to the damaged groups after six weeks of healing.
There were no significantly different groups at week 6. Measurements of the nerve fiber
diameters showed that the Crush group fibers had healed by week 6 as observed in Figure 9.

Table 4: 3-week Morphology Results
Groups

Fascicular
Area (mm2)

Fiber Count

Fiber density
(fiber/mm2)

Fiber packing
(%)

Mean g-ratio

Crush
LPC
Sham
Right Sciatic

0.492±0.087
0.636±0.105
0.597±0.067
0.437±0.109

4657±1646
5627±1176
6173±583
6767±1017

9246±2565
8847±2222
10456±1975
12880±3678

8±4
12±5
19±6
18±4

0.35±0.11
0.53±0.17
0.54±0.16
0.56±0.18
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Figure 8: Percentage of total fibers at each diameter at week 3 for the Right,
Sham, LPC and Crush groups.

Table 5: 6-week Morphology Results
Groups

Fascicular
Area (mm2)

Fiber Count

Fiber density
(fiber/mm2)

Fiber packing
(%)

Mean g-ratio

Crush
LPC
Sham
Right Sciatic

0.535±0.105
0.756±0.155
0.645±0.102
0.581±0.141

4076±1164
7143±1174
5633±2597
6894±1134

9416±900
9551±1013
8563±2597
13364±3513

11±3
12±3
13±4
15±3

0.53±0.12
0.53±0.18
0.54±0.16
0.56±0.14
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Figure 9: Percentage of total fibers at each diameter at week 6 for the Right, Sham, LPC
and Crush groups.

Discussion
This study established the extent of damage and subsequent regeneration that occurs from
crushing the nerve or injecting LPC into the nerve. Using age-matched experimental groups, a
difference was measured between damage from LPC and damage from a crush, while no
difference was measured between the control groups. The Right Sciatic Nerve group was used to
determine if there was nerve impairment in the Sham group during surgery. A lack of statistical
significance between the control groups in any of the measured parameters verifies that the
damage to the nerves was only done by either crushing the nerve or injecting it with LPC.
Surprisingly, the results of the gait and morphological parameters provide slightly
different results than the electrophysiological parameters. All parameters, except the fiber
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diameter profiles, suggest that the Crush group is different from the control groups through week
3. The electrophysiological parameters are the only parameters that suggest that the Crush is still
statistically different from the control groups at week 6. These parameters are used to establish
motor neuron healing. These results suggest that as long as there are a few fibers or axons
connected that the nerve can conduct regardless of the number of neurons that have healed. This
would explain why the Crush rats recovered their ability to walk normally by 6 weeks even
though the CMAPs portrayed that not all of the motor neurons were healed. The measurement of
the CMAP parameters may not be as accurate as anticipated, because the histological parameters
indicate that the nerve should be more healed than the CMAP amplitudes showed, see Tables 2
and 5.
A similar phenomenon was seen with the LPC groups. It was hypothesized that the LPC
would affect the nerve through the 3-week time point. Only the electrophysiological parameters
agreed with this hypothesis. Gait and morphological parameters showed that the LPC groups
were no different than the control groups. Due to the suggestion that the CMAP parameters may
not be as accurate as anticipated, the lack of an effect from LPC at week 3 may be due to either
too low of a concentration or too low of a dosage. To establish the duration and effects of the
LPC, different LPC concentrations and dosages need to be tested.
The mean g-ratio, total myelinated fiber count, and fiber diameter parameters determine
the Schwann cell damage and healing. In order to more accurately determine the extent of
damage to the Schwann cells, a set of rats should have been euthanized 2 days after receiving
surgery to establish a set of damaged morphological parameters. Since the morphological
parameters were only measured at week 3 and week 6, the data only shows whether or not the
Schwann cells have healed from the damage. These parameters do show that the Crush group
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Schwann cells were still damaged at week 3 but had healed by week 6. All other groups were
comparable across these parameters.
The fiber diameters all displayed a bi-modal distribution. Wolthers et al. (2005) show
that a bi-modal distribution is normal for rat nerves. The diameter data recorded lows at a 5 μm
diameter, which is the same location that Wolthers et al. (2005) recorded the low. The bi-modal
distribution is for both sensory and motor nerve types. It is not a separation between sensory and
motor nerves.
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ESTABLISHING THE EFFECT OF NGF AND LPC ON CRUSHED NERVES

With normal healing conditions established, the effectiveness of LPC-NGF combination
could be determined. The groups of nerves analyzed in this section include the LPC-NGF
(n=17), the Crush-LPC (n=17), the Crush-NGF (n=17), and the Crush-LPC-NGF (n=14) groups.
These groups were compared to either the previously established LPC or Crush groups. The
results were divided into the 3-week and 6-week time periods.
Gait Results
Gait measurements were carried out as previously outlined in section 4.2.1. Experimental
results are shown in Table 6 for the LPC-NGF, the Crush-LPC, the Crush-NGF, and the CrushLPC-NGF groups beginning with the day before surgery, week 0, through week 6. The LPCNGF group significantly deviated from the other groups until week 5. The LPC-NGF group did
not undergo as much damage as the other groups. There was no statistical difference between the
Crush-LPC, Crush-NGF, and Crush-LPC-NGF groups. Each of these groups lost nearly all use
of the left leg from the knee down after surgery. The values of the LPC-NGF group are
compared to the values of the LPC group in Figure 11. There was no statistical significance
between the LPC and LPC-NGF groups. The values of the Crush-LPC, Crush-NGF, and CrushLPC-NGF groups are compared to the values of the Crush group in Figure 10. There was no
statistical significance between the Crush, Crush-LPC, Crush-NGF, and Crush-LPC-NGF
groups. All crush group animals returned to full gait by week 6.
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Table 6: Gait Results for LPC-NGF, Crush-LPC, Crush-NGF, and Crush-LPC-NGF
groups
Group

Week 0

LPCNGF
CrushLPC
CrushNGF
CrushLPCNGF

Week 1

Week 2

Week 3

Week 4

Week 5

Week 6

21.00±0.00 13.71±2.19ǂ 17.53±2.02ǂ

19.78±1.10

20.95±0.10

20.96±0.09

20.91±.14

20.94±0.12

4.24±0.92ǂ

6.88±1.10ǂ

10.85±1.44ǂ 15.89±0.68ǂ 19.39±0.62ǂ 20.84±0.18

20.88±0.16

4.72±0.76ǂ

7.97±0.73ǂ

11.85±0.80ǂ 15.65±.073ǂ 19.10±0.50ǂ 20.71±0.22

20.93±0.14

4.46±0.83ǂ

7.12±1.10ǂ

10.19±1.35ǂ 14.94±0.70ǂ 18.31±0.73ǂ 20.63±0.23

ǂ indicates statistical differences from the control groups at that week, p<0.05.
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Figure 10: Gait comparison of the Crush, Crush-LPC, Crush-NGF, and Crush-LPCNGF groups. Error bars represent the 95% confidence intervals. ǂ indicates statistical
differences from the control groups at that week (p<0.05).
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Figure 11: Gait comparison of the Sham, LPC, and LPC-NGF groups. Error bars
represent the 95% confidence intervals. ǂ indicates statistical differences from the
control groups at that week (p<0.05).
Electrophysiology Results
Electrophysiology measurements, which were previously outlined in section 4.2.2, were
split into CMAP amplitudes and NCV values. The CMAP amplitudes are displayed in Table 7,
Figure 12, Figure 13 and Figure 14. The NCV values are displayed in Table 8, Figure 15, and
Figure 16. There was a small difference in the baseline values (Week 0) for each of the groups,
but all were statistically similar for both the CMAP amplitudes and NCVs.
Following surgery, an absence of CMAP amplitudes was observed in all of the groups
that received a crush. These groups slowly increased in CMAP amplitude across the 6-week
period until they recovered to between 15-18% of the baseline value. All six weeks were
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statistically different from week 0, but none of these groups were statistically different from each
other or from the Crush group (Figure 12). The LPC-NGF group sustained a decrease in CMAP
amplitudes following surgery and recovered by week 4. The LPC-NGF group statistically
differed from the two control groups through week 3, but was not statistically different from the
LPC group (Figure 13). The LPC-NGF group was statistically different from the crush groups
for all six weeks. NGF was effective in restoring damage caused by LPC, but neither NGF, LPC
nor the combination of NGF and LPC was able to restore the action potentials by 6 weeks after
crush injury.
The NCV measurements followed a similar pattern as the CMAP amplitudes for the
groups that received a crush and the LPC-NGF group. The groups with a crush had a
significantly different NCV for all six weeks from both the LPC-NGF group and the controls, but
were not significantly different from the Crush group (Figure 15). The LPC-NGF group NCVs
were significantly different than the control groups for the first three weeks, but not significantly
different from the LPC group (Figure 16).

Table 7: Electrophysiology Results for Crush-LPC, Crush-NGF, LPC-NGF, and CrushLPC-NGF groups
Group
LPCNGF
CrushLPC
CrushNGF
CrushLPCNGF

Week 0

Week 1

Week 2

Week 3

Week 4

Week 5

Week 6

8.54±1.57

9.10±0.88

9.29±0.65

10.41±0.53

11.14±0.63 0.34±0.20ǂ 0.76±0.29ǂ 1.00±0.40ǂ 1.01±0.26ǂ 1.23±0.27ǂ

1.72±0.31ǂ

10.58±1.72 0.40±0.23ǂ 0.65±0.33ǂ 0.71±0.42ǂ 0.90±0.28ǂ 1.24±0.23ǂ

1.86±0.28ǂ

11.80±1.30 0.34±0.21ǂ 0.77±0.34ǂ 0.88±0.42ǂ 0.92±0.38ǂ 1.56±0.40ǂ

2.31±0.52ǂ

11.15±0.81 5.92±1.68ǂ 7.79±1.64ǂ

ǂ indicates statistical differences from the control groups at that week, p<0.05.
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Figure 12: The amplitudes of the CMAPs for the Crush, Crush-LPC, Crush-NGF, and
Crush-LPC-NGF groups across all six weeks. Error bars represent the 95% confidence
intervals. ǂ indicates all groups are statistically different from the control groups (p<0.05).
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Figure 13. The amplitudes of the CMAPs for the Sham, LPC, and LPC-NGF groups. Error
bars represent the 95% confidence intervals. ǂ indicates LPC and LPC-NGF are
statistically different from the control group (p<0.05).
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Figure 14. Representative traces of the LPC-NGF, Crush-LPC, Crush-NGF, and CrushLPC-NGF group CMAPs for the day before surgery (pre-op), the day after surgery (day
1), the 3-week time point, and the 6-week time point.
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Table 8. NCV Results for Crush-LPC, Crush-NGF, LPC-NGF, and Crush-LPC-NGF
groups
Group
LPCNGF
CrushLPC
CrushNGF
CrushLPCNGF

Week 0

Week 1

Week 2

Week 3

Week 4

Week 5

Week 6

55.9±7.9

40.8±7.2ǂ

42.1±7.0

48.2±8.5

49.9±7.6

52.8±4.4

56.1±6.8

61.4±18.8

28.2±5.7ǂ

33.3±5.3ǂ

32.9±4.5ǂ

41.7±5.0

39.8±4.4

44.6±5.9

54.1±5.5

19.4±6.2ǂ

25.7±9.5ǂ

26.6±8.9ǂ

32.1±9.3

35.5±10.9 40.8±14.6

54.0±8.4

27.6±12.7ǂ

33.8±7.7ǂ

31.4±6.9ǂ

35.8±5.6

35.7±5.8

42.7±7.5

ǂ indicates statistical differences from the control groups at that week, p<0.05.
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Figure 15. The NCV values for the Crush, Crush-LPC, Crush-NGF, and Crush-LPCNGF groups across all six weeks. Error bars represent the 95% confidence intervals. ǂ
indicates statistical differences from the control groups at that week (p<0.05).
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Figure 16. The NCV values for the Sham, LPC, and LPC-NGF groups across all six
weeks. Error bars represent the 95% confidence intervals. ǂ indicates statistical
differences from the control groups at that week (p<0.05).

Morphology Results
Light microscopy was used to determine the healing of damaged nerves and the Schwann
cell’s ability to remyelinate axons. Regenerated nerve fiber profiles were examined at 3-weeks
and 6-weeks after damage, which were previously outlined in section 4.2.5. Table 9 compares
the total fascicular area, total myelinated fiber counts, fiber densities, fiber packing and g-ratio of
the LPC-NGF, Crush-LPC, Crush-NGF, and Crush-LPC-NGF groups after 3 weeks of healing.
The diameters of the nerve fibers were measured for each group (Figure 17 and Figure 18) with
all nerve fibers ranging between 0 and 20 µm for each group. None of the groups were statically
different from one another in fiber diameters. The Crush-LPC, Crush-NGF, and Crush-LPC-
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NGF groups were not significantly different in any parameter from each other and did not differ
from those of the Crush group. The LPC-NGF group was not statistically different from the LPC
group in any parameter.

Table 9. 3-week Morphology Results
Groups

Fascicular
Area (mm2)

Fiber
Count

Fiber density
(fiber/mm2)

Fiber
packing (%)

Mean gratio

LPC-NGF
Crush-LPC
Crush-NGF
Crush-LPC-NGF

0.637±0.187
0.640±0.088
0.572±0.073
0.634±0.073

7005±2312
6452±2438
6951±1782
6945±2718

10701±1880
9431±2397
11970±3037
10689±3378

15±2
13±2
17±7
9±5

0.53±0.14
0.35±0.07
0.34±0.12
0.36±0.08
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Figure 17. Percentage of total fibers at each diameter at week 3 for the Crush, CrushLPC, Crush-NGF, Crush-LPC-NGF groups.
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Figure 18. Percentage of total fibers at each diameter at week 3 for the Sham, LPC and
LPC-NGF groups.
Table 10 compares the total fascicular area, total myelinated fiber counts, fiber densities,
fiber packing and g-ratio of the LPC-NGF, Crush-LPC, Crush-NGF, and Crush-LPC-NGF
groups after 6 weeks of healing. There were no significantly different groups at week 6.
Measurements of the nerve fiber diameters showed that the groups that received a crush had
healed fibers by week 6 as observed in Figure 19 and Figure 20.
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Table 10. 6-week Morphology Results
Groups

Fascicular
Area (mm2)

Fiber Count

Fiber density
(fiber/mm2)

Fiber
packing (%)

Mean g-ratio

LPC-NGF
Crush-LPC
Crush-NGF
Crush-LPC-NGF

0.601±0.115
0.604±0.085
0.561±0.087
0.534±0.077

6730±1246
6177±1479
6877±2378
5202±2449

10515±2717
10245±1891
12308±3221
9772±3430

14±3
12±3
10±3
9±4

0.53±0.18
0.52±0.16
0.54±0.17
0.56±0.21
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Percentage of Total Fibers
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20%
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10%
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0%
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Fiber Diameter (μm)
Crush-NGF
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Figure 19. Percentage of total fibers at each diameter at week 6 for the Crush-LPC,
Crush-NGF, LPC-NGF, and Crush-LPC-NGF groups.
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Figure 20. Percentage of total fibers at each diameter at week 6 for the Sham, LPC and
LPC-NGF groups.
Discussion
This study established the extent of regeneration provided by a LPC-NGF combination
for a crushed nerve. Using age-matched experimental groups, no difference was measured in the
regeneration between a crushed nerve that received no treatment, a crushed nerve that received
NGF and a crushed nerve that received the LPC-NGF combination. As noted earlier in section
5.4, only the electrophysiological parameters suggested that crushed nerves were still statistically
different from the control groups at week 6. Due to the discrepancy of the electrophysiological
parameters, a better method of testing the motor neurons or a better procedure in collecting the
data may be needed to better match the other parameters of regeneration. Another point of
interest is that the electrophysiological parameters of the Crush-NGF data did not match that of
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previous experiments, such as Hoyng et al. (2014). This difference suggests the possibility that
the equipment produced different measurements in our lab or that operator variability influenced
the data.
The LPC-NGF group performed similarly to the LPC group, which was understandable,
once it was observed that the LPC did not provide the expected extent of damage to the nerves.
With NGF being injected at week 1 and LPC healed by week 3, there was not a sufficient
difference in time to distinguish between the two groups.
The mean g-ratio, total myelinated fiber count, and fiber diameter parameters showed that
the Schwann cells from the Crush-LPC, Crush-NGF, and the Crush-LPC-NGF groups were still
damaged at week 3 but had healed by week 6. All other groups were comparable across these
parameters.
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CONCLUSIONS AND RECOMMENDATIONS

In conclusion, the healing combination of LPC and NGF did not provide a faster
regeneration to a crushed nerve as hypothesized. In fact, it did not statistically perform any better
than just allowing the crushed nerve to heal on its own. However, the damage due to LPC was
reversed by NGF. With the findings that the electrophysiological parameters differed from the
gait and morphological parameters, only using two morphological time points did not provide
enough time points to determine a difference in the healing of the damaged rats. Also, with the
finding that a 0.1% concentration of LPC did not have as lasting an effect as desired, a higher
concentration of LPC may be needed in order to observe the desired effect.
After collecting and analyzing the electrophysiology data, the Crush-NGF group did not
perform as well as previous experiments, such as Hoyng et al. (2014). Due to this discrepancy,
two new hypotheses emerged: first, that too much variability may have been introduced by
having multiple operators perform the tests on each rat, and second, that there is possibly an
effect introduced by the equipment. Therefore experiments should be performed by a single
operator and the time points for data collection should be varied, to determine if the noticed
effects were caused by the equipment, human variability, neither or a combination. These
experiments are currently underway in the lab.
Future work should also include optimizing the concentrations and doses of LPC and
NGF. The concentrations tested were those that were given previously by the literature, but a
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combination had never been tried before. Also, the NGF concentration from literature was
determined in vitro, not in vivo.
Another area of future work should be analyzing the effect that LPC has on the nerve
during the first two weeks after being injected. This should be done by gathering histological
data at day 1, 3, 5, 7, 10 and 14. It is hypothesized that LPC may be inhibiting macrophage
ability to enter the damaged site due to the demyelination caused by the LPC.
Other work to be done should include testing the effects of giving the nerves multiple
doses of NGF while still giving the nerve a dose of LPC. It was determined while analyzing the
data that NGF did not show the same activity as previously thought. NGF half-life, which is on
the order of 4-6 hours, was then considered and determined that it may have the desired effect
but that the effect wears off too quickly to produce long-term effects. Therefore, testing should
be done to determine the effects that weekly and bi-weekly injections will have on the healing
rate of the crushed nerves.
Once the correct LPC and NGF dosages and concentrations are worked out and the
equipment is analyzed, the next stage is to take this model and move into cutting out sections of
nerve and replacing them with allografts. The allografts could consist of either decellularized
nerve conduits from cadavers or collagen fiber grafts. The grafts could then be combined with
the LPC and NGF to understand if the combination will also be beneficial in cut nerves.
An additional measurement to include in future studies is taking muscle weights at each
time point. This provides an additional measurement for the healing of the motor neurons. It will
also determine if there is any muscle atrophy occurring between the three and six week time
points.
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APPENDIX A

A.1 BBB Scale
0. No observable movement of the hindlimbs.
1. Slight (limited) movement of one or two joints, usually hip and/or knee.
2. Extensive movement of one joint or extensive movement of one joint and slight movement of
the other.
3. Extensive movement of two joints.
4. Slight movement of all three joints of the hindlimbs.
5. Slight movement of two joints and extensive movement of the third joint.
6. Extensive movement of two joints and slight movement of the third joint.
7. Extensive movement of the three joints in the hindlimbs.
8. Sweeping without weight bearing or plantar support of the paw without weight bearing.
9. Plantar support of the paw with weight bearing only in the support stage (i.e., when static) or
occasional, frequent or inconsistent dorsal stepping with weight bearing and no plantar stepping.
10. Plantar stepping with occasional weight bearing and no forelimb-hindlimb coordination.

57

11. Plantar stepping with frequent to consistent weight bearing and occasional forelimb-hindlimb
coordination.
12. Plantar stepping with frequent to consistent weight bearing and occasional forelimb-hindlimb
coordination.
13. Plantar stepping with frequent to consistent weight bearing and frequent forelimb-hindlimb
coordination.
14. Plantar stepping with consistent weight support, consistent forelimb-hindlimb coordination
and predominantly rotated paw position (internally or externally) during locomotion both at the
instant of initial contact with the surface as well as before moving the toes at the end of the
support stage or frequent plantar stepping, consistent forelimb-hindlimb coordination and
occasional dorsal stepping.
15. Consistent plantar stepping, consistent forelimb-hindlimb coordination and no movement of
the toes or occasional movement during forward movement of limb; predominant paw position is
parallel to the body at the time of initial contact.
16. Consistent plantar stepping and forelimb-hindlimb coordination during gait and movement of
the toes occurs frequently during forward movement of the limb; the predominant paw position
is parallel to the body at the time of initial contact and curved at the instant of movement.
17. Consistent plantar stepping and forelimb-hindlimb coordination during gait and movement of
the toes occurs frequently during forward movement of limb; the predominant paw position is
parallel to the body at the time of initial contact and at the instant of movement of the toes.
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18. Consistent plantar stepping and forelimb-hindlimb coordination during gait and movement of
the toes occurs consistently during forward movement of limb; the predominant paw position is
parallel to the body at the time of initial contact and curved during movement of the toes.
19. Consistent plantar stepping and forelimb-hindlimb coordination during gait and movement of
the toes occurs consistently during forward movement of limb; the predominant paw position is
parallel to the body at the instant of contact and at the time of movement of the toes, and the
animal presents a downward tail some or all of the time.
20. Consistent plantar stepping and forelimb-hindlimb coordination during gait and movement of
the toes occurs consistently during forward movement of limb; the predominant paw position is
parallel to the body at the instant of contact and at the time of movement of toes, and the animal
presents consistent elevation of the tail and trunk instability.
21. Consistent plantar stepping and coordinated gait, consistent movement of the toes; paw
position is predominantly parallel to the body during the whole support stage; consistent trunk
stability; consistent tail elevation.
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A.2 Scoring for Pain and Distress
Animals should be monitored for pain and distress as appropriate for the condition, procedure
and degree of invasiveness. The following scale may be used to monitor pain and
distress.
BODY WEIGHT
0
Normal
1
< 10% weight loss
2
10 - 15 % weight loss, eating
3
> 20% weight loss, not eating
APPEARANCE
0
Normal
1
Lack of grooming
2
Coat rough, possible nasal or ocular discharge
3
Coat very rough, abnormal posture, eyes sunken and
glazed
CLINICAL SIGNS
0
Normal
1
Diarrhea, constipation
2
Respiratory rate altered, respiratory depth altered, skin
tents
3
Cyanotic extremities, labored breathing
UNPROVOKED BEHAVIOR
0
Normal
1
Minor changes
2
Abnormal behavior, less mobile, less alert, inactive when
activity expected
3
Paralysis, inability to remain upright, shivering, convulsion
Total Score
The overall score may be tabulated and used to help assess the status of each animal.
•
•
•
•
•

A total score of 3 or less will be considered normal.
A total score of 4-6 will indicate some evidence of pain or discomfort.
A total score of 7-9 will suggest ample evidence of suffering with some type of
amelioration indicated.
A total score of 10-12 will be evidence of severe pain. Appropriate action must be taken
after consultation and recommendation from the University Veterinarian.
Any single score of 3 (severe) for an independent variable will automatically place the
animal in the 7-9 category.
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A.3 Approved IACUC
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